Open Source Pharma Foundation in the News
|
Why a Century-Old Vaccine Offers New Hope Against Pathogens
"The century-old BCG tuberculosis vaccine, accessible to billions, trusted by billions, and which costs only 15 cents a dose, shows 92% efficacy against COVID-19 in very small clinical trial by Professor Denise Faustman of Harvard Medical School. It is thought that the vaccine boosts the overall immune system. This exemplifies OSPF's 2+ year exploration of certain off patent vaccines, including BCG, against COVID-19, future pandemics and other diseases - a new scientific and legal/economic paradigm for vaccines. We cannot guarantee that they will work, but we absolutely must explore them. The New York Times article mentions OSPF. 'Imagine if we could use existing vaccines to curb pandemics — that would change world history,' Mr. Menon said."
|
|
Beyond the Booster Shot
"In 2016, Jaykumar Menon, a human-rights lawyer based in New York, founded the Open Source Pharma Foundation to address market failures in drug development... One of its goals is to create new vaccines that leverage trained immunity for what it calls 'ultra-broad spectrum' coverage." |
|
We should own our own livelihood and our own dream
"Open source research collaborations are an important and timely strategy to advance and possibly accelerate medical innovation," she says, "including in the area of neglected diseases where knowledge sharing is even more critical than in other fields. [...] When she came across an online "virtual laboratory" enabling researchers to carry out important work from home, she jumped at the chance to get involved..." |
|
Are open source principles the key to saving lives?
"Can open-source principles and collaborative innovation hold the key to solving the world’s most intractable health challenges? Alum Jaykumar Menon (MTRL 08-10) and his two nonprofits, the Open Source Pharma Foundation and the Double-Fortified Salt Project, are leading a global coalition to discover and distribute ultra-low cost biotech innovations at a scale of billons." |
|
Can Open-Source Vaccines Become A Reality For India?
"Joining on LRC is Jaykumar Menon, a human rights lawyer, who talks to Vishnu Som about a platform where scientists and researchers can freely access technological tools for researching diseases, share their discoveries and start new investigations into potential drugs. If the platform succeeds, it will allow drugs to succeed on their merit and need, rather than their ability to be profitable." |
|
Tata Trusts Support OSPF — the ‘Linux for drugs’
“The initiative borrows from the Linux model, where it is end-to-end open source, and publically funded. So data is made public at every stage for academics, non- governmental organisations, communities or drug companies to get involved and work on a research lead.” |
|
Open Source Covid Movement: A Non-Capitalist Alternative to Covid Control
"In many countries, open source activists are trying to find software to track people with Covid via mobile phone without losing privacy. In collaboration with the European Vaccine Initiative etc. The Open Source Pharma Foundation has started research on Covid vaccine discovery." |
|
FastCompany World Changing Ideas Awards 2020: AI and Data Finalists and Honorable MentionsOpen Source Pharma Foundation receives honorable mention for its work harnessing the power of data, machine learning, or artificial intelligence to understand the world and empower change
|
